Evidence map›Paper›PMID 24879085›Full record

ArticleOptometry and vision science : official publication of the American Academy of Optometry2014

Is renal function associated with early age-related macular degeneration?

Elaine W Chong, Robyn H Guymer, Ronald Klein, Barbara E Klein, Mary Frances Cotch, Jie Jin Wang, Michael G Shlipak, Tien Y Wong

Open access · greenAbstract read
In one paragraph

Article in Optometry and vision science : official publication of the American Academy of Optometry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Elaine W Chong*MBBS, PhD †MD, MPH ‡PhD §MD, PhD Centre for Eye Research Australia, the University of Melbourne, Victoria, Australia (EWC, RHG, JJW, TYW); Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin (RK, BEK); Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland (MFC); Centre for Vision Research, University of Sydney, Sydney, Queensland, Australia (JJW); Departments of Medicine, Epidemiology and Biostatistics, San Francisco VA Medical Center, University of California, San Francisco, California (MGS); and Singapore Eye Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore (TYW).
Robyn H Guymer
Ronald Klein
Barbara E Klein
Mary Frances Cotch
Jie Jin Wang
Michael G Shlipak
Tien Y Wong
San Francisco VA Medical Center · USUniversity of Melbourne · AU

Funding

Multi-ethnic Study Of Atherosclerosis - Vision ComponentZIAEY000403 · NEI · NATIONAL EYE INSTITUTE · PI COTCH, MARY FRANCES · 2009 to 2020
$1.8M
Adjunctive Use of Apyrase to Fibrinolytic TherapyR44HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2012 to 2013
$1.3M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--FIELD CENTERN01HC095165 · HC · WAKE FOREST UNIVERSITY · PI BURKE, GREGORY L · 1999 to 2001
$616k
Enhancing immune reconstitution after implantation of postnatal allogeneic thymusR21HL095165 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CROOKS, GAY M · 2008 to 2009
$440k
SUBCLINICAL CARDIOVASCULAR DISEASE COORDINATING CENTER-N01HC95159-268095159N01HC095159 · HC · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 1999 to 2006
$304k
Adjunctive Use of Apyrase to Fibrinolytic TherapyR43HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2009 to 2009
$226k
Multi-ethnic Study Of Atherosclerosis - Vision ComponentZ01EY000403 · NEI · NATIONAL EYE INSTITUTE · PI COTCH, MARY FRANCES · 2002 to 2008
$150k
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READINGN01HC095169 · HC · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI DETRANO, ROBERT · 1999 to 2001
$124k
Intramural NIH HHS Z01 EY000403Intramural NIH HHS Z99 EY999999Intramural NIH HHS ZIA EY000403NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01 HC095165NHLBI NIH HHS N01 HC095169NHLBI NIH HHS N01-HC-95159NHLBI NIH HHS N01-HC-95165NHLBI NIH HHS N01-HC-95169
6 · The paper itself

Abstract

purposeAge-related macular degeneration (AMD) and chronic kidney disease both involve immune dysregulation and may share underlying pathophysiologic changes to systemic homeostasis. Hence, we aim to evaluate associations between impaired kidney function and early AMD, in a search for urinary biomarkers for AMD.

methodsA population-based, cross-sectional analysis of persons aged 45 to 84 years was conducted with renal function measured using serum creatinine and cystatin C levels and the estimated glomerular filtration rate (eGFR) calculated. Age-related macular degeneration status was ascertained from retinal photographs.

resultsOf 5874 participants, 221 had early AMD. High serum cystatin C and low eGFR (≤60 ml/min/1.73 m) were not associated with early AMD in our multivariate analyses. Among normotensive persons, however, highest versus other deciles of cystatin C were associated with an increased prevalence of early AMD (odds ratio, 1.80; 95% confidence interval, 1.00 to 3.23).

conclusionsResults could not confirm an association between kidney function and early AMD. The borderline association between cystatin C and early AMD in normotensive persons require further verification.

Indexed as

AgedAged, 80 and overBiomarkersCreatinineCross-Sectional StudiesCystatin CFemaleGlomerular Filtration RateHumansKidneyMacular DegenerationMaleMiddle AgedOdds RatioRenal Insufficiency, ChronicBiomarkersCreatinineCystatin C

Identifiers

PMID24879085
PMCPMC4111798
OpenAlexW2042115705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.